Manipulation of transcription factor activity using fluorescein-tagged dumbbell oligonucleotides.
Steinmayr
M
M
Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development SA, Plan-les-Ouates, Switzerland.
Aubry
J P
JP
Becker-André
M
M
D001667:Binding, Competitive; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D005434:Flow Cytometry; D019793:Fluorescein; D005456:Fluorescent Dyes; D015870:Gene Expression; D006801:Humans; D019169:Jurkat Cells; D057094:Nuclear Receptor Subfamily 1, Group F, Member 1; D009841:Oligonucleotides / Q000737:chemistry* / Q000378:metabolism*; D010957:Plasmids; D011401:Promoter Regions, Genetic; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D011993:Recombinant Fusion Proteins; D012045:Regulatory Sequences, Nucleic Acid; D013601:T-Lymphocytes / Q000737:chemistry; D013937:Thymidine Kinase / Q000235:genetics; D015534:Trans-Activators / Q000378:metabolism*; D014157:Transcription Factors / Q000378:metabolism*; D014162:Transfection
D005456:Fluorescent Dyes; D057094:Nuclear Receptor Subfamily 1, Group F, Member 1; D009841:Oligonucleotides; D018160:Receptors, Cytoplasmic and Nuclear; D011993:Recombinant Fusion Proteins; D015534:Trans-Activators; D014157:Transcription Factors; D015500:Chloramphenicol O-Acetyltransferase; D013937:Thymidine Kinase; D019793:Fluorescein